WAKAMOTO PHARMACEUTICAL CO.,LTD.

Highlights Wakamoto Pharmaceutical Co.,Ltd.

Equities

4512

JP3991200001

Delayed Japan Exchange Other stock markets 04:46:04 16/05/2024 BST			5-day change	1st Jan Change
240 ^JPY	-0.83%		+4.33%	+13.15%

2021	Harrow Health, Inc. Enters into License Agreement and Basic Sale and Purchase Agreement with Wakamoto Pharmaceutical Co., Ltd	CI
2020	Wakamoto Pharmaceutical Co.,Ltd. to Postpone the Full-Year Financial Results Announcement for the Fiscal Year Ending March 31, 2020	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Final dividend	29/03/23	FA
Harrow Health, Inc. Enters into License Agreement and Basic Sale and Purchase Agreement with Wakamoto Pharmaceutical Co., Ltd	18/08/21	CI
Ex-dividend day for final dividend	27/03/18	FA
Ex-dividend day for final dividend	28/03/17	FA
Ex-dividend day for final dividend	28/03/16	FA
Ex-dividend day for final dividend	26/03/15	FA
Ex-dividend day for final dividend	26/03/14	FA
Kinki House Circulation Ltd. cancelled the acquisition of property in Higashi Yodogawa-ku from Wakamoto Pharmaceutical Co., Ltd..	10/04/13	CI
Kinki House Circulation Ltd. agreed to acquire property in Higashi Yodogawa-ku from Wakamoto Pharmaceutical Co., Ltd. for approximately ¥160 million.	02/11/12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer